Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 21,248	$ 16,034	$ 41,328	$ 29,522
General and administrative	4,917	4,302	9,455	8,453
Total operating expenses	26,165	20,336	50,783	37,975
Loss from operations	(26,165)	(20,336)	(50,783)	(37,975)
Other income (expense):
Interest income	1,396	1,312	2,831	2,432
Other expense:	(6)	(1)	(9)	(2)
Total other income	1,390	1,311	2,822	2,430
Net loss	(24,775)	(19,025)	(47,961)	(35,545)
Comprehensive loss:
Net loss	(24,775)	(19,025)	(47,961)	(35,545)
Other comprehensive loss:
Unrealized (loss) gain on securities	(50)	(22)	(320)	243
Comprehensive loss	$ (24,825)	$ (19,047)	$ (48,281)	$ (35,302)
Net loss per share, basic	$ (0.86)	$ (0.76)	$ (1.68)	$ (1.42)
Net loss per share, diluted	$ (0.86)	$ (0.76)	$ (1.68)	$ (1.42)
Weighted-average shares of common stock outstanding, basic	28,756,043	25,166,505	28,566,924	24,973,250
Weighted-average shares of common stock outstanding, diluted	28,756,043	25,166,505	28,566,924	24,973,250